EFTA02498392.pdf

From: Peter Attia < > Sent: Sunday, June 28, 2015 8:37 PM To: jeffrey E. Subject: RE: Heard back from my lipid gurus/mentors Yes, I think we'll try livalo, ubiquone, trilipix, metformin + big nutrition/exercise overhaul. Is your doc going to handle or do you want me to? I don't like stepping on docs toes. I If you can't tolerate the livalo, we'll definitely move to PCSK9i in summer. From: jeffrey E. [mailto:[email protected]] Sent: Sunday, June 28, 2015 1:35 PM To: Peter Attia Subject: Re: Heard back from my lipid gurus/mentors statins? On Sun, Jun 28, 2015 at 4:33 PM, Peter Attia > wrote: Yes, they agree with diagnosis. We have much to discuss. They think it's crazy that you're walking around with no meds on board! From: jeffrey E. [mailto:[email protected] <mailto:[email protected]> ] Sent: Sunday, June 28, 2015 1:31PM To: Peter Attia Subject: Re: Heard back from my lipid gurus/mentors did they agree with your 2b etc on Sun, Jun 28, 2015 at 4:14 PM, Peter Attia > wrote: EFTA_R1_01623760 EFTA02498392 Regarding your "interesting" case. Peter Attia I Nutrition Science Initiative (NuSI) <http://www.nusi.org/> I President I (m) I > (o) I www.nusi.org <http://www.nusi.org/> Confidentiality Notice: This e-mail is confidential and intended only for the recipients listed above. If you have received this e-mail in error, please delete it immediately and inform the sender of the error or contact [email protected] <mailto:[email protected]> please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected] <mailto:[email protected]> , and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved please note The information contained in this communication is confidential, may be attorney-client privileged, may constitute inside information, and is intended only for the use of the addressee. It is the property of JEE Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited and may be unlawful. If you have received this communication in error, please notify us immediately by return e-mail or by e-mail to [email protected] <mailto:[email protected]> , and destroy this communication and all copies thereof, including all attachments. copyright -all rights reserved 2 EFTA_R1_01623761 EFTA02498393